NCT01017042View on ClinicalTrials.gov

Pharmacokinetic Study of an Acute Gout Regimen

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

September 30, 2007

Study Completion Date

October 31, 2007

Conditions
Pharmacokinetics
Interventions
DRUG

colchicine tablets

colchicine 1.2mg initially; then an additional 0.6mg orally 1 hour later (1.8mg over 2 hours)

Trial Locations (1)

58104

PRACS Institute, Ltd. - Cetero Research, Fargo

Sponsors
All Listed Sponsors
lead

Mutual Pharmaceutical Company, Inc.

INDUSTRY

NCT01017042 - Pharmacokinetic Study of an Acute Gout Regimen | Biotech Hunter | Biotech Hunter